Published in J Psychosom Res on October 04, 2000
A randomised controlled trial of a self-management plan for patients with newly diagnosed angina. Br J Gen Pract (2002) 2.11
The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J Psychosom Res (2011) 1.63
Cost-effectiveness of enhanced depression care after acute coronary syndrome: results from the Coronary Psychosocial Evaluation Studies randomized controlled trial. Arch Intern Med (2012) 1.51
Depression and prognosis following hospital admission because of acute myocardial infarction. CMAJ (2003) 1.25
AAFP guideline for the detection and management of post-myocardial infarction depression. Ann Fam Med (2009) 1.20
Increased anxiety and depression in Danish cardiac patients with a type D personality: cross-validation of the Type D Scale (DS14). Int J Behav Med (2009) 1.10
Comparison of prevalence of symptoms of depression, anxiety, and hostility in elderly patients with heart failure, myocardial infarction, and a coronary artery bypass graft. Heart Lung (2010) 1.09
Presence of depression and anxiety before and after coronary artery bypass graft surgery and their relationship to age. BMC Psychiatry (2007) 1.06
The relationship between depressive symptoms, health service consumption, and prognosis after acute myocardial infarction: a prospective cohort study. BMC Health Serv Res (2008) 0.99
The association between depressive symptoms and non-psychiatric hospitalisation in older adults. PLoS One (2012) 0.97
Why do patients with long-term conditions use unscheduled care? A qualitative literature review. Health Soc Care Community (2012) 0.95
Depression and rehospitalization following acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2011) 0.90
Twelve-month cost-effectiveness of telephone-delivered collaborative care for treating depression following CABG surgery: a randomized controlled trial. Gen Hosp Psychiatry (2014) 0.89
The association between depressive symptoms in the community, non-psychiatric hospital admission and hospital outcomes: a systematic review. J Psychosom Res (2014) 0.88
A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): study protocol. BMC Cardiovasc Disord (2011) 0.84
Impact of briefly-assessed depression on secondary prevention outcomes after acute coronary syndrome: a one-year longitudinal survey. BMC Health Serv Res (2006) 0.83
Depression and coronary heart disease. ISRN Cardiol (2012) 0.82
Inpatient and outpatient costs in patients with coronary artery disease and mental disorders: a systematic review. Biopsychosoc Med (2015) 0.82
Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD). Trials (2009) 0.77
The current status of heart-mind relationships. J Psychosom Res (2000) 0.75
Mental illness and cardiovascular mortality: searching for the links. CMAJ (2007) 0.75
Design and rationale for a randomized controlled trial to reduce readmissions among patients with depressive symptoms. Contemp Clin Trials (2015) 0.75
Psychiatric readmissions and their association with physical comorbidity: a systematic literature review. BMC Psychiatry (2017) 0.75
Cost-effectiveness analysis of dronedarone versus other anti-arrhythmic drugs for the treatment of atrial fibrillation--results for Canada, Italy, Sweden and Switzerland. Eur J Health Econ (2012) 0.75
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Depression following myocardial infarction. Impact on 6-month survival. JAMA (1993) 8.64
Depression and 18-month prognosis after myocardial infarction. Circulation (1995) 7.22
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet (1997) 4.65
Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N Engl J Med (2000) 4.27
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med (2000) 3.32
Clinical, angiographic, and hemodynamic findings in patients with anomalous origin of the coronary arteries. Circulation (1976) 3.11
Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med (1988) 3.03
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med (1984) 2.70
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Complication rate of coronary arteriography. A review of 5250 cases studied by a percutaneous femoral technique. Circulation (1976) 2.40
Gender, depression, and one-year prognosis after myocardial infarction. Psychosom Med (1999) 2.39
Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation (1981) 2.36
Social support, depression, and mortality during the first year after myocardial infarction. Circulation (2000) 2.25
Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation (1990) 2.13
Depression and 1-year prognosis in unstable angina. Arch Intern Med (2000) 2.13
Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol (2000) 2.04
Cilazapril and early atherosclerotic changes after balloon injury of porcine carotid arteries. Circulation (1992) 1.99
Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med (1997) 1.86
New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome. Circulation (2001) 1.83
Aspirin versus heparin to prevent myocardial infarction during the acute phase of unstable angina. Circulation (1993) 1.74
Effect of coronary bypass surgery on survival patterns in subsets of patients with left main coronary artery disease. Report of the Collaborative Study in Coronary Artery Surgery (CASS). Am J Cardiol (1981) 1.74
Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation (1990) 1.72
Myocardial bridging and milking effect of the left anterior descending coronary artery: normal variant or obstruction? Am J Cardiol (1976) 1.71
Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). CASS Participating Investigators and Staff. J Am Coll Cardiol (1993) 1.66
How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med (1996) 1.62
The importance of clinical subsets in interpreting maximal treadmill exercise test results: the role of multiple-lead ECG systems. Circulation (1979) 1.61
The impact of negative emotions on prognosis following myocardial infarction: is it more than depression? Health Psychol (1995) 1.60
Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. Circulation (1997) 1.56
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med (1988) 1.55
Success, safety, and late electrophysiological outcome of low-energy direct-current ablation in patients with the Wolff-Parkinson-White syndrome. Circulation (1992) 1.55
Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation (1997) 1.51
Prevention of restenosis after angioplasty in small coronary arteries with probucol. Circulation (1998) 1.51
Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia. Circulation (2000) 1.51
Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J (2002) 1.50
Better functional status in American than Canadian patients with heart disease: an effect of medical care? J Am Coll Cardiol (1995) 1.50
Evaluation of patients with chest pain and normal coronary angiograms. Arch Intern Med (2001) 1.48
Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation (1984) 1.48
Sauna-induced myocardial ischemia in patients with coronary artery disease. Am J Med (1999) 1.47
Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. J Am Coll Cardiol (1998) 1.44
Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study. J Am Coll Cardiol (1994) 1.43
New substrates for the fluorometric determination of oxidative enzymes. Anal Chem (1968) 1.43
Antiarrhythmic drug therapy in the Multicenter UnSustained Tachycardia Trial (MUSTT): drug testing and as-treated analysis. J Am Coll Cardiol (2001) 1.42
Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). Circulation (1999) 1.39
Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med (1992) 1.36
The Asymptomatic Cardiac Ischemia Pilot (ACIP) study: design of a randomized clinical trial, baseline data and implications for a long-term outcome trial. J Am Coll Cardiol (1994) 1.34
Mutations in the gerP locus of Bacillus subtilis and Bacillus cereus affect access of germinants to their targets in spores. J Bacteriol (2000) 1.33
Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease. Am J Cardiol (1973) 1.33
Myocardial infarction patients in the 1990s--their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol (1996) 1.31
Institutional differences in therapeutic decision making in the Coronary Artery Surgery Study (CASS). Med Decis Making (1986) 1.31
Biocompatibility aspects of new stent technology. J Am Coll Cardiol (1998) 1.30
Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am J Cardiol (1978) 1.26
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
Improved efficiency of treadmill exercise testing using a multiple lead ECG system and basic hemodynamic exercise response. Circulation (1978) 1.24
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol (2000) 1.22
Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries. Circulation (1982) 1.22
Asymptomatic Cardiac Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic cardiac ischemia randomized to medical therapy or revascularization. The ACIP Investigators. J Am Coll Cardiol (1995) 1.22
Use of survival analysis to determine the clinical significance of new Q waves after coronary bypass surgery. Circulation (1983) 1.21
A method for complementation analysis of nuclear and chloroplast mutants of photosynthesis in chlamydomonas. Genetics (1980) 1.19
Over-production, purification and properties of the uridine-diphosphate-N-acetylmuramate:L-alanine ligase from Escherichia coli. Eur J Biochem (1995) 1.19
Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences. Circulation (1985) 1.17
Influence of aortocoronary saphenous vein bypass surgery on left ventricular volumes and ejection fraction. Comparison before and one year after surgery in 51 patients. Am J Med (1973) 1.17
Transvenous catheter ice mapping and cryoablation of the atrioventricular node in dogs. Pacing Clin Electrophysiol (1999) 1.16
Clinical implications of a reduction in psychological distress on cardiac prognosis in patients participating in a psychosocial intervention program. Psychosom Med (2001) 1.16
Feasibility of cardiac cryoablation using a transvenous steerable electrode catheter. J Interv Card Electrophysiol (1998) 1.16
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. J Hepatol (1999) 1.15
Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation (1983) 1.14
Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation (1979) 1.14
Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. Circulation (1990) 1.13
The effects of inhalation of 100 percent oxygen on myocardial lactate metabolism in coronary heart disease. Am J Cardiol (1969) 1.12
The Canadian Registry of Atrial Fibrillation: a noninterventional follow-up of patients after the first diagnosis of atrial fibrillation. Am J Cardiol (1998) 1.12
Proton magnetic resonance investigation of the conformational properties of the basic pancreatic trypsin inhibitor. FEBS Lett (1973) 1.10
Serial angiograpic evaluation in 60 consecutive patients with aorto-coronary artery vein grafts 2 weeks, 1 year, and 3 years after operation. J Thorac Cardiovasc Surg (1974) 1.10
Follow-up of atrial fibrillation: The initial experience of the Canadian Registry of Atrial Fibrillation. Eur Heart J (1996) 1.10
Selective coronary arteriography by the percutaneous femoral artery approach. Am J Roentgenol Radium Ther Nucl Med (1969) 1.09
Discrepancies between cineangiographic and postmortem findings in patients with coronary artery disease and recent myocardial revascularization. Circulation (1974) 1.09
Angiographic changes in aortocoronary vein grafts: lack of progession beyond the first year. Circulation (1973) 1.07
Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study. Circulation (2001) 1.07
Comparative mechanisms of antiarrhythmic drug action in experimental atrial fibrillation. Importance of use-dependent effects on refractoriness. Circulation (1993) 1.07
Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group. J Card Surg (2000) 1.06
Clinical significance of selective coronary cinearteriography. Can Med Assoc J (1968) 1.06
Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration. Am J Cardiol (1984) 1.05
Pulsed doppler echocardiographic study of mitral stenosis. Circulation (1980) 1.05
Non-invasive pulsed Doppler study of mitral stenosis and mitral regurgitation: preliminary study. Br Heart J (1979) 1.05